Tumor Biology

, Volume 35, Issue 11, pp 11565–11569 | Cite as

Prognostic value of TROP2 expression in patients with gallbladder cancer

  • Min-Bin Chen
  • Hai-Feng Wu
  • Yan Zhan
  • Xing-Li Fu
  • Ai-Kun Wang
  • Li-Sheng Wang
  • Hai-Ming Lei
Research Article
First Online:
Received:
Accepted:

Abstract

Altered expression of TROP2 is observed in various types of human cancers. However, the clinical significance and pathological role of TROP2 in gallbladder cancer (GBC) remains unclear. The main objective of this investigation was to clarify the relationships between TROP2 expression and the clinicopathological features of patients with GBC. Immunohistochemistry was performed to investigate the expression of TROP2 and epithelial-mesenchymal transition (EMT) indicator proteins in 93 patients with GBC. Immunohistochemistry showed that the protein expression level of TROP2 was significantly higher in GBC tissues than in adjacent noncancerous tissues. In addition, immunohistochemistry analysis showed that TROP2 expression was significantly correlated with histologic grade (P = 0.038), tumor stage (P = 0.015), and lymph node metastasis (P = 0.007). Furthermore, high TROP2 expression was significantly associated with a loss of the epithelial marker E-cadherin (P = 0.013) and acquisition of expression of the mesenchymal marker vimentin (P = 0.031). Kaplan-Meier analysis and Cox proportional hazards regression models were used to investigate the correlation between TROP2 expression and prognosis of GBC patients. Kaplan-Meier analysis indicated that patients with high TROP2 expression had poor overall survival (P < 0.001). Multivariate analysis showed that high TROP2 expression was an independent predictor of overall survival. In conclusion, our data suggest for the first time that the increased expression of TROP2 in GBC is associated significantly with aggressive progression and poor prognosis. In conclusion, this study confirmed that TROP2 might be involved in regulating the EMT and malignant progression in GBC. It also provided the first evidence that TROP2 expression in GBC was an independent prognostic factor of patients, which might be a potential diagnostic and therapeutic target of GBC.

Keywords

TROP2 EMT Gallbladder cancer 
This is a preview of subscription content, log in to check access.

Notes

Conflicts of interest

None

References

  1. 1.
    Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96. doi: 10.3322/CA.2007.0010.PubMedCrossRefGoogle Scholar
  2. 2.
    Jayaraman S, Jarnagin WR. Management of gallbladder cancer. Gastroenterol Clin North Am. 2010;39:331–42, x. doi:  10.1016/j.gtc.2010.02.006.
  3. 3.
    Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol. 2004;11:310–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Reid KM, Ramos-De la Medina A, Donohue JH. Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg. 2007;11:671–81Google Scholar
  5. 5.
    de Aretxabala X, Roa I, Burgos L, Losada H, Roa JC, Mora J, et al. Gallbladder cancer: an analysis of a series of 139 patients with invasion restricted to the subserosal layer. J Gastrointest Surg. 2006;10:186–92.PubMedCrossRefGoogle Scholar
  6. 6.
    Ootani T, Shirai Y, Tsukada K, Muto T. Relationship between gallbladder carcinoma and the segmental type of adenomyomatosis of the gallbladder. Cancer. 1992;69:2647–52.PubMedCrossRefGoogle Scholar
  7. 7.
    Roa JC, Tapia O, Cakir A, Basturk O, Dursun N, Akdemir D, et al. Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas. Mod Pathol. 2011;24:1069–78. doi: 10.1038/modpathol.2011.68.PubMedCrossRefGoogle Scholar
  8. 8.
    Park SB, Kim YH, Rho HL, Chae GB, Hong SK. Primary carcinosarcoma of the gallbladder. J Korean Surg Soc. 2012;82:54–8. doi: 10.4174/jkss.2012.82.1.54.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Ripani E, Sacchetti A, Corda D, Alberti S. Human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer. 1998;76:671–6. doi: 10.1002/(SICI)1097-0215(19980529)76:5<671::AID-IJC10>3.0.CO;2-7 .PubMedCrossRefGoogle Scholar
  10. 10.
    El Sewedy T, Fornaro M, Alberti S. Cloning of the murine TROP2 gene: conservation of a PIP2-binding sequence in the cytoplasmic domain of TROP-2. Int J Cancer. 1998;75:324–30. doi: 10.1002/(SICI)1097-0215(19980119)75:2<324::AID-IJC24>3.0.CO;2-B .PubMedCrossRefGoogle Scholar
  11. 11.
    Faulk WP, Temple A, Lovins RE, Smith N. Antigens of human trophoblasts: a working hypothesis for their role in normal and abnormal pregnancies. Proc Natl Acad Sci U S A. 1978;75:1947–51.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Linnenbach AJ, Wojcierowski J, Wu SA, Pyrc JJ, Ross AH, Dietzschold B, et al. Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733. Proc Natl Acad Sci U S A. 1989;86:27–31.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Cubas R, Li M, Chen C, Yao Q. Trop2: a possible therapeutic target for late stage epithelial carcinomas. Biochim Biophys Acta. 2009;1796:309–14. doi: 10.1016/j.bbcan.2009.08.001.PubMedGoogle Scholar
  14. 14.
    Sukhthankar M, Alberti S, Baek SJ. (−)-Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cells. Anticancer Res. 2010;30:2497–503.Google Scholar
  15. 15.
    Fong D, Spizzo G, Gostner JM, Gastl G, Moser P, Krammel C, et al. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol. 2008;21:186–91.PubMedGoogle Scholar
  16. 16.
    Nakashima K, Shimada H, Ochiai T, Kuboshima M, Kuroiwa N, Okazumi S, et al. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer. 2004;112:1029–35.PubMedCrossRefGoogle Scholar
  17. 17.
    Mühlmann G, Spizzo G, Gostner J, Zitt M, Maier H, Moser P, et al. TROP2 expression as prognostic marker for gastric carcinoma. J Clin Pathol. 2009;62:152–8. doi: 10.1136/jcp.2008.060590.PubMedCrossRefGoogle Scholar
  18. 18.
    Wang J, Day R, Dong Y, Weintraub SJ, Michel L. Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol Cancer Ther. 2008;7:280–5. doi: 10.1158/1535-7163.MCT-07-2003.PubMedCrossRefGoogle Scholar
  19. 19.
    Fong D, Moser P, Krammel C, Gostner JM, Margreiter R, Mitterer M, et al. High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer. 2008;99:1290–5. doi: 10.1038/sj.bjc.6604677.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Bignotti E, Todeschini P, Calza S, Falchetti M, Ravanini M, Tassi RA, et al. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Eur J Cancer. 2010;46:944–53. doi: 10.1016/j.ejca.2009.12.019.PubMedCrossRefGoogle Scholar
  21. 21.
    Kim MA, Lee HS, Lee HE, Kim JH, Yang HK, Kim WH. Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology. 2009;54:442–51. doi: 10.1111/j.1365-2559.2009.03247.x.PubMedCrossRefGoogle Scholar
  22. 22.
    Lee HK1, Cho MS, Kim TH. Prognostic significance of muc4 expression in gallbladder carcinoma. World J Surg Oncol. 2012;10:224. doi:  10.1186/1477-7819-10-224.

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Min-Bin Chen
    • 1
  • Hai-Feng Wu
    • 2
  • Yan Zhan
    • 1
  • Xing-Li Fu
    • 3
  • Ai-Kun Wang
    • 4
  • Li-Sheng Wang
    • 4
  • Hai-Ming Lei
    • 4
  1. 1.Department of Medical Oncology, Kunshan First People’s HospitalJiangsu UniversityKunshanChina
  2. 2.Department of Critical Care Medicine, Affiliated Yixing People’s HospitalJiangsu UniversityYixingChina
  3. 3.School of MedicineJiangsu UniversityZhenjiangChina
  4. 4.Department of General Surgery Yancheng Third People’s HospitalThe Affiliated Yancheng Hospital of Southeast University Medical CollegeYanchengChina

Personalised recommendations